Full Text
Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden

Abstract

Authors

TM Baker VF Paly S Thybo M Hultberg R Minacori S Kotapati J Sabater

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×